Seeing Machines Limited
("Seeing Machines" or the "Company")
RESULTS FOR THE SIX MONTHS TO 31 DECEMBER 2012
Seeing Machines Limited (AIM:SEE) is pleased to announce its unaudited results for the six months ended 31 December 2012.
Seeing Machines creates face and eye tracking products that help machines understand people. As a world leader in the development of computer vision related technology, our products improve driver safety, diagnose ophthalmic health issues, and power next-gen products.
Highlights:
· Total Revenue for the half year increased 50% to A$5,693,634 (December half 2011: A$3,794,960);
o DSS revenues increased by 87% to $3,699,553 (December half 2011: $1,981,396) with significant new business growth derived from North America, South America and Africa.
o Order backlog at 31 December 2012 of over $3,000,000 helping to secure future revenues
· Increase in gross profit of 57% to A$2,887,500 (December half 2011: A$1,839,243) due primarily to growth in DSS sales;
· Net loss decreased by A$623,010 to A$317,919 (December half 2011: loss of A$936,801);
· Cash at 31 December 2012 increased to A$927,518 (30 June 2012: A$578,022) mainly as a result of the capital raising of $1,962,664 completed in October 2012.
Commenting on the Results, Seeing Machines CEO, Ken Kroeger said: "Seeing Machines has continued to invest in extending its position in the mining and resource sector. This increased effort has helped us identify many new and exciting opportunities that are now turning into major DSS contracts. During the first half we have designed improved DSS technology that has successfully completed customer acceptance trials and will be brought to market in the first quarter of 2013-14.
"Given the mining sector's emerging focus on output and efficiency and the role that DSS plays in improving driver alertness and safety, we are seeing a growing sales pipeline and new strategic opportunities. This provides us with increased confidence in the company's performance for the full year and beyond."
For further information, please contact:
Seeing Machines Limited Ken Kroeger, CEO |
+61 2 6103 4700 or ken.kroeger@seeingmchines.com |
Terry Winters, Chairman |
+61 411 411 111 or terry.winters@seeingmachines.com |
finnCap |
|
Ed Frisby |
+44 20 7220 0566 or efrisby@finncap.com |
Ben Thompson |
+44 20 7220 0572 or bthompson@finncap.com |
Walbrook PR Ltd |
+44 20 7933 8780 or seeing@walbrookpr.com |
Helen Westaway |
+44 7841 917 679 +44 7827 879 460 |
Your directors submit their report for the half-year ended 31 December 2012.
The names of the Company's directors in office during the half-year and until the date of this report are as below. Directors were in office for this entire period unless otherwise stated.
Terry Winters |
Non-Executive Chairman |
|
Ken Kroeger |
Managing Director & CEO |
|
David Gaul |
Non-Executive Director |
|
Rob Sale |
Non-Executive Director |
To 28 November 2012 |
Alex Zelinsky |
Non-Executive Director |
|
Michael Roberts |
Non-Executive Director |
From 13 January 2013 |
The company achieved revenues of A$4,686,796 from the sale of goods and services and A$1,006,838 from other income resulting in total revenue for the half year to 31 December 2012 of A$5,693,634 (2011: A$3,794,960).
The first six months of trading in the 2013 financial year were a significant improvement over the corresponding period in the 2012 financial year. This was primarily driven by significant growth in demand for its DSS products, evidenced by both the large increase in sales revenue realised in the period from this source, but also the increase in orders on hand at period end, amounting to more than $3 million in value.
The company made a net loss of A$317,919 for the six months to 31 December 2012 compared to a net loss of A$936,801 for the period to 31 December 2011. This result represents a significant improvement in operational outcomes.
Operational highlights for the half-year include:
· Continued growth of the DSS pipeline with new customers and expansion at existing sites across customers and regions;
· Strong backlog of orders at end of first half to underpin next quarter revenues;
· Next generation of DSS prototypes built and delivering very good field test results;
· New partnership opportunities for the DSS which will increase global channels to market;
· Development of new services offerings for the DSS enhancing our overall DSS offering and diversifying revenue opportunities;
· >87% increase in DSS revenues (A$3,699,553 compared to A$1,981,396 for the corresponding period in 2011);
· Development of next generation Eye Tracking technology to enhance all areas of product commercialisation;
· TrueField progress and potential for JV or licensing in 2013.
Financial Results
The company achieved revenues of A$4,686,796 (2011: A$3,048,410) from sale of goods and services and A$1,006,838 (2011: A$746,550) from other income resulting in total revenue for the half year to 31 December 2012 of A$5,693,634 (2011: A$3,794,960).
Revenue for the half year for each of the three products; DSS, faceAPI and faceLAB, and Other Income compared to the same period last year is shown in the following table.
Product |
31 December 2012 $ |
31 December 2011 $ |
Variance % |
DSS |
3,699,553 |
1,981,396 |
+87 |
faceLAB |
693,870 |
861,697 |
-19 |
faceAPI |
293,373 |
205,317 |
+43 |
Other income |
1,006,838 |
746,550 |
+34 |
Total Revenue |
5,693,634 |
3,794,960 |
+50 |
The high value of the Australian dollar against the US, Euro and Great Britain currencies has had a negative impact on revenue earned from those regions over the period. Cost of sales at A$1,799,296 (2011: A$1,209,167) was up due to higher revenues whilst the proportionate cost was relatively static at 38% of revenue as opposed to 39% of revenue for the corresponding period in 2011. Net expenditure for the half-year was A$4,212,257, up from A$3,522,594 for the period to 31 December 2011, reflecting the increased investment in the period targeted toward additional Research and Development, and increased activity in DSS sales, distribution and marketing.
The Net Loss for the six months to 31 December 2012 was better than budget at A$317,919, and a significant decrease of $618,882 compared to the net loss of A$936,801 for the period to 31 December 2011. Post half-year report balance sheet date, in February 2013, the accrued R&D Tax Offset of $1,000,211 with respect to the 2012 Income Tax Return of the company was received. This was treated as other income and recognised in the first half of the current 2013 financial year.
Cash at 31 December 2012 was A$927,518 compared to A$578,022 at 30 June 2012 and A$1,070,433 at 31 December 2011.
In October 2012, the company completed a capital raising of A$1,962,664.
Operational Highlights
DSS
DSS revenues were A$3,699,553 for the six months to 31 December 2012, reflecting a substantial increase over A$1,981,396 achieved for the six months to 31 December 2011. This was the result of the strong demand for the product range following an extended period of mine site trials that are now converting into sales, and the company's success in growing its customer base with a broader geographic spread. Revenue was generated from:
· sales of DSS units;
· software licensing;
· installation services;
· maintenance and support fees;
· field support services; and
· DSSi information reporting services including event classification.
Customer locations now include North and South America, Africa, Australia, Mongolia and Indonesia. Notably there was a significant expansion in sales to locations outside Australia and the United States.
To accommodate growth and access to customers, the company has commenced the relocation of the DSS sales and services arms of the business to larger premises in Tucson Arizona. This will allow the organisation to offer a full service, inventory storage and maintenance for the DSS platform across the Americas.
A number of opportunities to extend the DSS to market are also being pursued. Over 80 DSS units have been installed in large road-legal transport trucks that operate on a combination of private mining roads and public highways in Australia. This represents an entry into a new market for the product from which we expect ongoing uptake. The technology is being modified for original equipment manufacturer (OEM) opportunities in the wider automotive market.
In terms of R&D, the focus remains aimed at improvements in hardware ruggedisation and reliability, new software features and the development of a real-time situational risk awareness reporting system that will further support the mitigation of fatigue related operator risk.
For the remainder of this financial year we will focus our energies on expansion of the DSS business through:
· closing a number of significant deals in the sales pipeline that will further entrench the DSS as the superior product for the mining industry;
· addressing the backlog of outstanding orders ;
· further building the DSS team capability to support our customers in their use of the product;
· improving our logistics and business systems to streamline quotations, orders and fulfilment
· furthering R&D aimed at keeping the technology ahead of its competitors,
· incorporating feedback and features that our existing customers need; and
· progressing the partnership opportunities that will expand our routes to market.
faceAPI
faceAPI achieved revenue of A$293,373 (2011: A$205,317) for the six months to 31 December 2012.
The Company has started offering integration services for our core technology, known as faceAPI. This is expected to lead to ongoing engineering revenue and to additional production license sales and royalties.
faceLAB
faceLAB achieved revenue of A$693,870 (2011: A$861,697) for the six months to 31 December 2012, a reduction of 19% over the six months to 31 December 2011.
The drop in revenue can be attributed to aging of this product, which will be addressed through the planned near-term release of new product versions incorporating next-generation precision eye-tracking technology. This exciting new technology will also support existing and future products across the range of Seeing Machines' product platforms.
TrueField
The Glaucoma-related laboratory trials performed by our technology partners at the Australian National University (ANU) have recently been completed. In response to the positive results, we will initiate an independent to validate performance in lead up to the next commercialisation steps.
The domain experts continue to believe that the product will have applicability beyond glaucoma in eye diseases such as Age Related Macular Degenerations and Diabetic Retinopathy.
The Directors remain committed to delivering significant growth in shareholder value and expect results for the full year to 30 June 2013 to be in line with existing market expectations.
The demand for DSS products and services by the mining and resource industry is substantial and is expected to continue to underpin most of the company's revenue and profit growth over the next two to three years.
During this time the company will be developing new markets in road transport, bus and segments where machine and plant operators face significant risk of fatigue and distraction.
Terry Winters Chairman 22 March 2013 |
Ken Kroeger Managing Director & CEO 22 March 2013 |
Statement of Financial Position
|
|
|
Consolidated |
|
|
|
|
31 DEC 2012 |
30 JUN 2012 |
AS AT 31 DECEMBER 2012 |
|
A$ |
A$ |
|
ASSETS |
|
|
|
|
CURRENT ASSETS |
|
|
|
|
Cash and cash equivalents |
|
927,518 |
578,022 |
|
Trade and other receivables |
|
2,804,225 |
1,656,303 |
|
Inventories |
|
332,549 |
86,151 |
|
Other current assets |
|
17,856 |
222,139 |
|
TOTAL CURRENT ASSETS |
|
4,082,147 |
2,542,615 |
|
|
|
|
|
|
NON-CURRENT ASSETS |
|
|
|
|
Property, plant and equipment |
|
364,538 |
256,254 |
|
Intangible assets |
|
426,836 |
479,573 |
|
TOTAL NON-CURRENT ASSETS |
|
791,374 |
735,827 |
|
|
|
|
|
|
TOTAL ASSETS |
|
4,873,521 |
3,278,442 |
|
|
|
|
|
|
LIABILITIES |
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
Trade and other payables |
|
1,319,911 |
1,515,610 |
|
Provisions |
|
426,733 |
408,717 |
|
TOTAL CURRENT LIABILITIES |
|
1,746,644 |
1,924,327 |
|
|
|
|
|
|
NON-CURRENT LIABILITIES |
|
|
|
|
Provisions Non-Current |
|
233,628 |
203,966 |
|
TOTAL NON-CURRENT LIABILITIES |
|
233,628 |
203,966 |
|
|
|
|
|
|
TOTAL LIABILITIES |
|
1,980,272 |
2,128,293 |
|
|
|
|
|
|
NET ASSETS |
|
2,893,249 |
1,150,149 |
|
|
|
|
|
|
EQUITY |
|
|
|
|
Contributed equity |
|
17,088,651 |
15,024,112 |
|
Accumulated losses |
|
(14,885,379) |
(14,567,460) |
|
Other reserves |
|
689,977 |
693,497 |
|
TOTAL EQUITY |
|
2,893,249 |
1,150,149 |
The above statement of financial position should be read in conjunction with the accompanying notes.
|
|
|
Consolidated |
|
|
|
|
2012 |
2011 |
FOR THE HALF-YEAR ENDED 31 December 2012 |
|
A$ |
A$ |
|
Continuing operations |
|
|
|
|
Sale of goods and license fees |
|
4,114,298 |
2,623,901 |
|
Rendering of services |
|
572,498 |
424,509 |
|
Revenue |
|
4,686,796 |
3,048,410 |
|
|
|
|
|
|
Cost of Sales |
|
(1,799,296) |
(1,209,167) |
|
|
|
|
|
|
Gross Profit |
|
2,887,500 |
1,839,243 |
|
|
|
|
|
|
Other income |
|
1,006,838 |
746,550 |
|
|
|
|
|
|
Research and Development Expenses |
|
(774,711) |
(607,318) |
|
Distribution Expenses |
|
(563,669) |
(291,208) |
|
Marketing expenses |
|
(897,160) |
(597,348) |
|
Occupancy and facilities expenses |
|
(371,206) |
(376,270) |
|
Administration and support expenses |
|
(1,538,572) |
(1,701,382) |
|
Other expenses |
|
(69,939) |
50,932 |
|
Loss before income tax |
|
(317,919) |
(936,801) |
|
|
|
|
|
|
Income tax expense |
|
- |
- |
|
|
|
|
|
|
Loss after income tax |
|
(317,919) |
(936,801) |
|
|
|
|
|
|
Net Loss for the period |
|
(317,919) |
(936,801) |
|
|
|
|
|
|
Other comprehensive income |
|
|
|
|
Foreign currency translation - items that may be reclassified subsequently to profit or loss |
|
(3,520) |
(7,648) |
|
Other comprehensive income net of tax |
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
(321,439) |
(944,449) |
|
|
|
|
|
|
Earnings per share for profit attributable to the ordinary |
|
|
|
|
equity holders of the company: |
|
|
|
|
· Basic earnings per share |
|
(0.077) |
(0.226) |
|
· Diluted earnings per share |
|
(0.077) |
(0.226) |
The above statement of comprehensive income should be read in conjunction with the accompanying notes.
|
|
|
|
||||
|
|
|
Contributed Equity |
Accumulated Losses |
Foreign Currency Translation Reserve |
Employee Equity Benefits Reserve |
Total Equity |
FOR THE HALF-YEAR ENDED 31 DECEMBER 2012 |
|
A$ |
A$ |
A$ |
A$ |
A$ |
|
|
|
|
|
|
|
|
|
At 1 July 2011 |
|
14,813,612 |
(12,832,383) |
44,994 |
648,259 |
2,674,482 |
|
Loss for the half-year |
|
- |
(936,801) |
- |
- |
(936,801) |
|
Other comprehensive income |
|
- |
- |
(7,648) |
- |
(7,648) |
|
Total comprehensive income |
|
- |
(936,801) |
(7,648) |
- |
(944,449) |
|
|
|
|
|
|
|
|
|
Transaction with owner in their capacity as owner |
|
|
|
|
|
|
|
Shares Issued |
|
210,500 |
- |
- |
- |
210,500 |
|
|
|
|
|
|
|
|
|
At 31 December 2011 |
|
15,024,112 |
(13,769,184) |
37,346 |
648,259 |
1,940,533 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 July 2012 |
|
15,024,112 |
(14,567,460) |
45,238 |
648,259 |
1,150,149 |
|
Loss for the half-year |
|
- |
(317,919) |
- |
- |
(317,919) |
|
Other comprehensive income |
|
- |
- |
(3,520) |
- |
(3,520) |
|
Total comprehensive income |
|
- |
(317,919) |
(3,520) |
- |
(321,439) |
|
|
|
|
|
|
|
|
|
Transaction with owner in their capacity as owner |
|
|
|
|
|
|
|
Shares Issued |
|
2,064,539 |
- |
- |
|
2,064,539 |
|
|
|
|
|
|
|
|
|
At 31 December 2012 |
|
17,088,651 |
(14,885,379) |
41,718 |
648,259 |
2,893,249 |
The above statement of changes in equity should be read in conjunction with the accompanying notes.
|
|
|
|||||
|
|
|
|
Consolidated |
|||
|
|
|
|
2012 |
2011 |
||
|
FOR THE HALF-YEAR ENDED 31 December 2012 |
|
A$ |
A$ |
|||
|
|
|
|
|
|
||
|
Cash flows from operating activities |
|
|
|
|||
|
Receipts from customers |
|
4,860,046 |
3,132,981 |
|||
|
Receipt of R&D tax offset |
|
- |
702,803 |
|||
|
Payment to suppliers and employees |
|
(6,171,125) |
(4,388,295) |
|||
|
Interest received |
|
6,627 |
21,747 |
|||
|
Net cash flows used in operating activities |
|
(1,304,452) |
(530,764) |
|||
|
|
|
|
|
|
||
|
Cash flows from investing activities |
|
|
|
|||
|
Purchase of plant and equipment |
|
(143,116) |
(11,029) |
|||
|
Payments for intangible assets |
|
(16,415) |
(28,912) |
|||
|
Net cash flows used in investing activities |
|
(159,531) |
(39,941) |
|||
|
|
|
|
|
|
||
|
Cash flows from financing activities |
|
|
|
|||
|
Proceeds from issue of shares |
|
1,832,414 |
- |
|||
|
Cost of Capital Raising |
|
(15,415) |
|
|||
|
Net cash flows from financing activities |
|
1,816,999 |
- |
|||
|
|
|
|
|
|||
|
Net decrease in cash and cash equivalents |
|
353,016 |
(570,705) |
|||
|
Net foreign exchange differences |
|
(3,520) |
(7,648) |
|||
|
Cash and cash equivalents at beginning of period |
|
578,022 |
1,648,786 |
|||
|
Cash and cash equivalents at end of period |
|
927,518 |
1,070,433 |
|||
The above statement of cash flows should be read in conjunction with the accompanying notes.